Announcement on Voluntary Disclosure of Subsidiary Passing the U.S. FDA On-site Inspection

About this update from Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class A

Announcement on Voluntary Disclosure of Subsidiary Passing the U.S. FDA On-site Inspection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class A